AdBio Partners SAS. (7/11/23). "Press Release: AdBio Partners Strengthens Its Management Team and Promotes Clément Bertholet as Partner". Paris.

	Organisation	AdBio Partners SAS (AFB)
	Group	AdBio Partners (Group)
	Organisation 2	France (govt)
	Product	venture capital
	Product 2	LIFE SCIENCES
	Person	Bertholet, Clément (Calida Therapeutics 202304– CEO + Operating Partner at AdBio Partners before Thabor Therapeutics)
	Person 2	Huriez, Alain (Advent France Biotechnology 201704 Managing Partner before Advent Life Sciences + TcLand + Neovacs)

AdBio partners, a leading venture capital firm specialized in company building and early-stage investments in Life Sciences startups, today announces that it strengthens its management team and promotes Clément Bertholet as Partner.

In his new role, Clément joins the partnership of AdBio partners, which currently manages two funds and has 23 companies in its portfolio.

“Clément’s promotion to the position of Partner comes off the back of two years of close and fruitful collaboration with AdBio partners and we are delighted to welcome him today in the partnership. Clément brings a strong knowledge in deal negotiations, corporate finance, public institutions relations, company management and molecular biology as demonstrated through his key contributions in several companies in our portfolio.” said Alain Huriez, MD, co-founder and chairman of AdBio partners.

Clément Bertholet holds a MSc in molecular biology and health from Ecole Normale Supérieure (ENS Paris-Saclay) with a major in oncology. After several lab experiences in Curie Institute (Paris) and Cancer Research UK (London), he joined the Corps des Mines, a French senior official corpse of which he is engineer in chief. As such, he spent 8 years working in several positions at the French Ministry of Finance, BNP Paribas CIB New York, and Suez.

Clément Bertholet says: “I am delighted and grateful to Alain Huriez and Geoffroy de Ribains for the opportunity to join AdBio partners’ management team as partner. I am very much looking forward to supporting our current portfolio to solve unmet clinical need for patients, as well as to drive performance for our investors. Company creation and seed financing in therapeutic biotech companies is challenging but highly rewardable, I am really pleased to fully commit to this underserved venture capital segment, which is in my view the Life Sciences value chain’s instrumental stage.”

Before joining Adbio partners, Clément was Deputy Governmental Delegate for Business Restructuring directly reporting to the finance, industry, and labor ministers as well as Head of restructuring unit with achievement of several distressed M&A deals, more than 20k jobs saved in highly sensitive cases, and creation and management of a €500m credit line to support companies facing bankruptcy during the COVID-19 crisis.

About AdBio partners

AdBio partners (previously Advent France Biotechnology) is an AMF-regulated (the French financial market authority) company that invests in a range of sectors within life sciences - specifically in therapeutics-oriented projects.

Its unique strategy combines early-stage investments in promising enterprises and strong entrepreneurial support to strengthen the company’s growth.

Created in 2016, AdBio partners has made 23 European investments in France, Belgium, Spain and Ireland with two funds AFB Seed Fund I* and AFB FII.

AdBio partners has developed strong relationships within the European innovation ecosystem; as a result, it has attracted international VC syndicates to its portfolio companies.

The operational team includes investment professionals with long-standing track records in entrepreneurial ventures, combined with strong scientific, medical and operational expertise.

www.adbio.partners

*AFB Seed Fund I is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing

Press and analyst contacts

AdBio Partners
contact@adbio.partners

Record changed: 2024-09-12